Screening utilization among cancer survivors: a meta-analysis

Uhlig, Annemarie; Mei, Janet; Baik, Inhye; Meyer, Christian; Uhlig, Johannes

doi:10.1093/pubmed/fdx030

Cited by 18 publications

(14 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of the cancer screening practices for cancer survivors in the USA, United Kingdom, and Canada were reported in cross-sectional surveys with self-reported or insurance data. The reported cancer types were limited to breast, cervical, colorectal, and prostate cancer [ 17 ]. However, the previously reported practice rate of cancer screening in cancer survivors does not provide insight on whether appropriate cancer screening for cancer survivors is performed.…”

Section: Discussionmentioning

confidence: 99%

Trends in Participation Rates of the National Cancer Screening Program among Cancer Survivors in Korea

Yun

Hong

Her

et al. 2020

Cancers

View full text Add to dashboard Cite

The study aimed to describe the participation rates of the National Cancer Screening Program (NCSP) among cancer survivors in Korea. The NCSP protocol recommends that all Korean men and women should be screened for cancer. Cancer survivors were defined as those registered for any cancer in the Korea Central Cancer Registry by December 31 of the year prior to being included in the target population of the NCSP. In this study, the participation rates for the NCSP were calculated as the percentage of people who participated in four kinds of cancer screening programs, independently. The average annual percentage change was assessed. The participation rates of the general population and cancer survivors were higher than 40% in stomach, breast, and cervical cancer screening. These rates were higher than that of colorectal cancer screening in 2014. In addition, the participation rates in the NCSP in 2002–2014 increased for all cancer types. The NCSP participation rates of the cancer survivors indicate the high demand for cancer screening. Further research may investigate the effect of the NCSP on second cancer occurrence or mortality in cancer survivors and the significance of cancer screening guidelines for cancer survivors.

show abstract

Section: Discussionmentioning

confidence: 99%

Trends in Participation Rates of the National Cancer Screening Program among Cancer Survivors in Korea

Yun

Hong

Her

et al. 2020

Cancers

View full text Add to dashboard Cite

show abstract

“…We report high levels of enthusiasm, possibly reflecting views in the general population towards cancer screening and the positive perceptions of screening held by cancer survivors, 23,24 who are known to be more likely to participate in cancer screening than noncancer survivors. 25,26 LCS research to date has focussed on ever smokers. In this study, we found that HL survivors differ from ever smokers in that they perceive early-stage lung cancer as curable, thereby differentiating them from ever smokers who frequently report fatalistic attitudes as a barrier to undergoing LCS.…”

Section: Theme 3: Concerns and Potential Barriers To Participationmentioning

confidence: 99%

The perspectives of survivors of Hodgkin lymphoma on lung cancer screening: A qualitative study

Broadbent

Gorman

Armitage

et al. 2021

Health Expectations

View full text Add to dashboard Cite

Background: Hodgkin lymphoma survivors (HLS) are at excess risk of lung cancer as a consequence of HL treatment. HLS without a heavy smoking history are currently unable to access lung cancer screening (LCS) programmes aimed at ever smokers, and there is an unmet need to develop a targeted LCS programme. In this study we prospectively explored HLS perspectives on a future LCS programme, including motivating factors and potential barriers to participation, with the aim of identifying ways to optimise uptake in a future programme.Methods: Semistructured telephone interviews were conducted with HLS, aged 18-80 and lymphoma-free for ≥5 years, selected from a clinical database (ADAPT).Participants provided informed consent. Data were analysed using inductive thematic analysis.Results: Despite awareness of other late effects, most participants were unaware of their excess risk of lung cancer. Most were willing to participate in a future LCS programme, citing the potential curability of early-stage lung cancer and reassurance as motivating factors, whilst prior experience of healthcare was a facilitator. Whilst the screening test (a low dose CT scan) was considered acceptable, radiation risk was a concern for some and travel and time off work were potential barriers to participation.Conclusions: Our results suggest that most HLS would participate in a future LCS programme, motivated by perceived benefits. Their feedback identified a need to develop educational materials addressing lung cancer risk and concerns about screening, including radiation risk. Such materials could be provided upon an invitation to LCS. Uptake in a future programme may be further optimized by offering flexible screening appointments close to home.

show abstract

“…However, uptake of lung cancer screening by ever smokers has been suboptimal; the UK-based Lung Screen Uptake Study reported a 53% uptake rate, the highest reported rate among historically low uptake rates for lung cancer screening pilots and trials [15]. That said, uptake of cancer screening is higher among cancer survivors than non-cancer survivors [16,17] and in a qualitative study in the UK, HL survivors were motivated to participate in a future lung cancer screening programme and reported few barriers to participation [18]. However, it is likely that some of the sociodemographic and psychological barriers to cancer screening in the general public will also apply to HL survivors.…”

Section: Introductionmentioning

confidence: 99%

Likely uptake of a future lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study

et al. 2022

View full text Add to dashboard Cite

Background Many Hodgkin lymphoma (HL) survivors are at increased risk of subsequent malignant neoplasms (SMN), including lung cancer, due to previous treatment for HL. Lung cancer screening (LCS) detects early-stage lung cancers in ever smokers but HL survivors without a heavy smoking history are ineligible for screening. There is a rationale to develop a targeted LCS. The aim of this study was to investigate levels of willingness to undergo LCS in HL survivors, and to identify the psycho-social factors associated with screening hesitancy. Methods A postal questionnaire was sent to 281 HL survivors registered in a long-term follow-up database and at increased risk of SMNs. Demographic, lung cancer risk factors, psycho-social and LCS belief variables were measured. Multivariable logistic regression analysis was performed to determine the factors associated with lung cancer screening hesitancy, defined as those who would ‘probably’ or ‘probably not’ participate. Results The response rate to the questionnaire was 58% (n = 165). Participants were more likely to be female, older and living in a less deprived area than non-participants. Uptake (at any time) of breast and bowel cancer screening among those previously invited was 99% and 77% respectively. 159 participants were at excess risk of lung cancer. The following results refer to these 159. Around half perceived themselves to be at greater risk of lung cancer than their peers. Only 6% were eligible for lung cancer screening pilots aimed at ever smokers in the UK. 98% indicated they would probably or definitely participate in LCS were it available. Psycho-social variables associated with LCS hesitancy on multivariable analysis were male gender (OR 5.94 CI 1.64–21.44, p < 0.01), living in an area with a high index of multiple deprivation decile (deciles 6–10) (OR 8.22 CI 1.59–42.58, p < 0.05) and lower levels of self-efficacy (OR 1.64 CI 1.30–2.08 p < 0.01). Conclusion HL survivors responding to this survey were willing to participate in a future LCS programme but there was some hesitancy. A future LCS trial for HL survivors should consider the factors associated with screening hesitancy in order to minimise barriers to participation.

show abstract

Screening utilization among cancer survivors: a meta-analysis

Cited by 18 publications

References 29 publications

Trends in Participation Rates of the National Cancer Screening Program among Cancer Survivors in Korea

Trends in Participation Rates of the National Cancer Screening Program among Cancer Survivors in Korea

The perspectives of survivors of Hodgkin lymphoma on lung cancer screening: A qualitative study

Likely uptake of a future lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study

Contact Info

Product

Resources

About